This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Katie Ching, PhD
Research Investigator at Ligand Pharmaceuticals, Inc.

Profile

Dr. Ching is a Research Investigator at Ligand Pharmaceuticals in Emeryville, CA. She received her Ph.D in Biochemistry and Molecular Biology from Georgetown University, followed by post-doctoral studies at the National Institutes of Health in Bethesda, Maryland. At Ligand, she has been responsible for the evaluation and characterization of transgenic chickens used for the discovery of human antibodies. The original transgenic platform, OmniChickenTM, has been used for antibody discovery programs by pharmaceutical industry partners since 2016.

Agenda Sessions

  • OmniClic: Transgenic Chickens Producing Human Antibodies for Bispecifics

    8:45am
  • OmniClic: Transgenic Chickens Producing Human Antibodies for Bispecifics

    On Demand